Clinical trial
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
NCT00106028 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- March 31, 2010
- Enrollment
- 143 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.